![Page 1: Dual PTEN/P53 suppression promotes high grade sarcomas by activating Notch](https://reader035.vdocuments.us/reader035/viewer/2022081419/56816685550346895dda2e13/html5/thumbnails/1.jpg)
Dual PTEN/P53 suppression promotes high
grade sarcomas by activating Notch
Eva Hernando, Ph.D.
![Page 2: Dual PTEN/P53 suppression promotes high grade sarcomas by activating Notch](https://reader035.vdocuments.us/reader035/viewer/2022081419/56816685550346895dda2e13/html5/thumbnails/2.jpg)
• Genomic complexity • Low number of known recurrent genetic
mutations• Limited enrolment of patients in clinical
trials
Challenges in the study of high grade sarcoma and
leiomyosarcoma
better understanding of the molecular basismouse models that recapitulate human disease
Preclinical testing (immunotherapy)
![Page 3: Dual PTEN/P53 suppression promotes high grade sarcomas by activating Notch](https://reader035.vdocuments.us/reader035/viewer/2022081419/56816685550346895dda2e13/html5/thumbnails/3.jpg)
• N=40 specimens (NYU School of Medicine and Northwestern University)
• Platform: OncoMap3 core and extended panels (1047 mutations in 116 genes)
• 73 candidate mutations on 44 genes• 6 confirmed mutations on 2 genes:
– TP53 (one V157F and two R273C amino acid substitutions).
– a low-frequency germ-line single-nucleotide polymorphism in EGFR (S703F)
Targeted sequencing revealed low incidence of mutations in classical
‘cancer genes’
Guijarro et al., AJP 2013
![Page 4: Dual PTEN/P53 suppression promotes high grade sarcomas by activating Notch](https://reader035.vdocuments.us/reader035/viewer/2022081419/56816685550346895dda2e13/html5/thumbnails/4.jpg)
Partial PTEN and TP53 deletions are common in HGUPS and LMS
Barretina et al., Nat Gen 2010
Guijarro et al., AJP 2013
![Page 5: Dual PTEN/P53 suppression promotes high grade sarcomas by activating Notch](https://reader035.vdocuments.us/reader035/viewer/2022081419/56816685550346895dda2e13/html5/thumbnails/5.jpg)
PTEN and TP53 expression is commonly downregulated in HGUPS and LMS
Guijarro et al., AJP 2013
![Page 6: Dual PTEN/P53 suppression promotes high grade sarcomas by activating Notch](https://reader035.vdocuments.us/reader035/viewer/2022081419/56816685550346895dda2e13/html5/thumbnails/6.jpg)
Smooth-muscle specific conditional inactivation of Pten and p53
Tagln-cre/ Ptenwtp53wt
Tagln-cre/ PtenL/+p53L/+
Tagln-cre/ PtenL/+
p53wt
Tagln-cre/ Ptenwtp53L/+
Tagln-cre/ PtenL/Lp53wt
Tagln-cre/ Ptenwtp53L/L
Tagln-cre+/+ PtenL/L p53L/L
Tagln-cre+/- /PtenL/+p53L/+F1 Tagln-cre+/- /PtenL/+ p53L/+
F2
F0
![Page 7: Dual PTEN/P53 suppression promotes high grade sarcomas by activating Notch](https://reader035.vdocuments.us/reader035/viewer/2022081419/56816685550346895dda2e13/html5/thumbnails/7.jpg)
PtenD/+p53D/+ mice have shorter overall survival than Pten+/+p53D/+
Guijarro et al., AJP 2013Hernando et al., Nat Med 2007
![Page 8: Dual PTEN/P53 suppression promotes high grade sarcomas by activating Notch](https://reader035.vdocuments.us/reader035/viewer/2022081419/56816685550346895dda2e13/html5/thumbnails/8.jpg)
PtenD/+p53D/+ mice have increased sarcoma incidence compared to
Pten+/+p53D/+
Guijarro et al., AJP 2013
![Page 9: Dual PTEN/P53 suppression promotes high grade sarcomas by activating Notch](https://reader035.vdocuments.us/reader035/viewer/2022081419/56816685550346895dda2e13/html5/thumbnails/9.jpg)
PtenD/+p53D/+ HGS histologically resemble the equivalent human lesions
Guijarro et al., AJP 2013
![Page 10: Dual PTEN/P53 suppression promotes high grade sarcomas by activating Notch](https://reader035.vdocuments.us/reader035/viewer/2022081419/56816685550346895dda2e13/html5/thumbnails/10.jpg)
Tagln-cre marks smooth muscle cells
Guijarro et al., 2013
Tagln-cre+/+ x ROSA26-loxP-STOP-loxP-LacZ
![Page 11: Dual PTEN/P53 suppression promotes high grade sarcomas by activating Notch](https://reader035.vdocuments.us/reader035/viewer/2022081419/56816685550346895dda2e13/html5/thumbnails/11.jpg)
Tagln-cre is also expressed in mesenchymal stem cells
![Page 12: Dual PTEN/P53 suppression promotes high grade sarcomas by activating Notch](https://reader035.vdocuments.us/reader035/viewer/2022081419/56816685550346895dda2e13/html5/thumbnails/12.jpg)
Murine HGUPS have complex karyotypes
![Page 13: Dual PTEN/P53 suppression promotes high grade sarcomas by activating Notch](https://reader035.vdocuments.us/reader035/viewer/2022081419/56816685550346895dda2e13/html5/thumbnails/13.jpg)
Liver
Pancreas Lung
PtenD/+p53D/+ HGUPS are highly metastatic
![Page 14: Dual PTEN/P53 suppression promotes high grade sarcomas by activating Notch](https://reader035.vdocuments.us/reader035/viewer/2022081419/56816685550346895dda2e13/html5/thumbnails/14.jpg)
Pten is haploinsufficient for sarcoma tumor progression
No mutation
PtenD/+p53D/+ Pten+/+p53D/+
![Page 15: Dual PTEN/P53 suppression promotes high grade sarcomas by activating Notch](https://reader035.vdocuments.us/reader035/viewer/2022081419/56816685550346895dda2e13/html5/thumbnails/15.jpg)
Which advantage does Pten downregulation
confer to p53 deficient sarcomas?
![Page 16: Dual PTEN/P53 suppression promotes high grade sarcomas by activating Notch](https://reader035.vdocuments.us/reader035/viewer/2022081419/56816685550346895dda2e13/html5/thumbnails/16.jpg)
PtenD/+/p53D/+ bone-marrow mesenchymal stem cells display higher clonability and
proliferationPtenL/+/p53L/+ and Pten+/+/p53L/+ bone marrow-derived mouse mesenchymal stem cells+ Adeno-cre infection
Colony formation assay Proliferation assay
Both, acute and genetically induced concomitant inactivation of Pten and P53 leads toincreased clonogenic and proliferative capacity of mesenchymal stem cells
![Page 17: Dual PTEN/P53 suppression promotes high grade sarcomas by activating Notch](https://reader035.vdocuments.us/reader035/viewer/2022081419/56816685550346895dda2e13/html5/thumbnails/17.jpg)
Pten suppression in Pten+/+/p53D/+ tumor cells increases clonogenic capacity and
invasion
![Page 18: Dual PTEN/P53 suppression promotes high grade sarcomas by activating Notch](https://reader035.vdocuments.us/reader035/viewer/2022081419/56816685550346895dda2e13/html5/thumbnails/18.jpg)
The Notch signaling pathway is up-regulated in PtenΔ/+Tp53Δ/+ murine HGUPS
![Page 19: Dual PTEN/P53 suppression promotes high grade sarcomas by activating Notch](https://reader035.vdocuments.us/reader035/viewer/2022081419/56816685550346895dda2e13/html5/thumbnails/19.jpg)
The Notch signaling pathway is up-regulated in PtenΔ/+Tp53Δ/+ murine HGUPS
![Page 20: Dual PTEN/P53 suppression promotes high grade sarcomas by activating Notch](https://reader035.vdocuments.us/reader035/viewer/2022081419/56816685550346895dda2e13/html5/thumbnails/20.jpg)
Gamma-secretase inhibition suppresses the clonogenic and invasive potential of tumor cells
GSI
Colony formation assay
![Page 21: Dual PTEN/P53 suppression promotes high grade sarcomas by activating Notch](https://reader035.vdocuments.us/reader035/viewer/2022081419/56816685550346895dda2e13/html5/thumbnails/21.jpg)
shPten pro-oncogenic effects are counteracted by Notch inhibition
Colony formation assay invasion assay
![Page 22: Dual PTEN/P53 suppression promotes high grade sarcomas by activating Notch](https://reader035.vdocuments.us/reader035/viewer/2022081419/56816685550346895dda2e13/html5/thumbnails/22.jpg)
Model of molecular classification of high grade sarcoma patients for targeted therapies
![Page 23: Dual PTEN/P53 suppression promotes high grade sarcomas by activating Notch](https://reader035.vdocuments.us/reader035/viewer/2022081419/56816685550346895dda2e13/html5/thumbnails/23.jpg)
Conclusions• Conditional inactivation of Pten and p53 in mouse
mesenchymal progenitors recapitulates the histological and cytogenetic features of human HGUPS and LMS
• Pten deficiency confers increased clonogenic and invasive potential to p53 heterozygous sarcoma cells
• Pten suppression in p53 deficient MSCs and tumor cells triggers Notch signaling
• Gamma-secretase inhibitors negate the pro-oncogenic effects of Pten suppression in p53 deficient sarcoma cellsPTEN/TP53 deficient HGUPS may be susceptible
to Notch inhibition
![Page 24: Dual PTEN/P53 suppression promotes high grade sarcomas by activating Notch](https://reader035.vdocuments.us/reader035/viewer/2022081419/56816685550346895dda2e13/html5/thumbnails/24.jpg)
Hernando LabMaria V. GuijarroLaura DanielsonMiguel SeguraMartha VegaAvital GazielSilvia Menendez
Luca PaoluzziDoug HannifordRaffaella Di MiccoLisa KoetzBarbara FontanalsElena SokolovaVivien LowOlivia BlackburnRana MoubarakVeronica DavalosPraveen Agrawal
CollaboratorsSonika DahiyaJian Jun WeiCarlos Cordon-CardoPier Paolo Pandolfi
Funding
American Cancer SocietyEdna´s Foundation of HopeLiddy Shriver Sarcoma IntiativeSarcoma Foundation of AmericaMelanoma Research AllianceDODNIH/NCINIH/NIAMS